EP4011369A1 — Aqueous pharmaceutical composition comprising tapentadol tartrate
Assigned to GL Pharma GmbH · Expires 2022-06-15 · 4y expired
What this patent protects
The present invention relates to an aqueous pharmaceutical composition with a pH value within the range of 4.0 to 5.5, wherein the composition comprises tapentadol tartrate, wherein the composition does not comprise a preservative, and wherein the composition does not comprise a …
USPTO Abstract
The present invention relates to an aqueous pharmaceutical composition with a pH value within the range of 4.0 to 5.5, wherein the composition comprises tapentadol tartrate, wherein the composition does not comprise a preservative, and wherein the composition does not comprise a buffer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.